Dual inhibition of cannabinoid CB1 recceptor and inducible NOS attenuates obesity-induced chronic kidney disease. Udi S, Hinden L, Ahmad M, Drori A, Iyer MR, Cinar R, Herman-Edelstein M, Tam J. British Journal of Pharmocology. 9/20/2018.